Re-purposed Buildings: Finding Success Before the Bulldozers

As long as cities continue to evolve, there will be issues of abandoned spaces. Ideas about what to do with them are as diverse as the cities themselves. Some have been temporarily repurposed as community kitchens, and there is even a movement pushing to transform old shopping malls into homeless shelters, as they can function as a sort of transitional community for those in need.

There is also a divide between those who view the buildings as crumbling eyesores bringing down property values, and those who delight in their potential. There have been some highly successful conversions, and the possibilities seem nearly endless.

The Fenix Food Factory in Rotterdam, for example, repurposed a former warehouse into a fun, contemporary eatery, and its success spurred the revitalization of the entire neighborhood. Similarly, a new creative district is underway in Liverpool in a massive endeavor to transform the old tobacco warehouse at Stanley Dock into luxury flats and shops.

On American soil, the Highland Mall project is considered one of the most successful instances of adaptive reuse ever attempted. When the shopping mall in Austin, Texas, began to die a slow death during the first decade of this millennium, the nearby Austin Community College stepped in, purchased the space via bond election in 2010, and created a “learning emporium,” complete with 604 computer stations, 200,000 square feet of instructional space, a library, and offices.

The transformation created hundreds of jobs, and in development are plans for a regional-workforce center, a STEM simulator lab, a digital-media center, and a culinary and hospitality center. Phase one opened in 2014, with Phase two on the calendar to debut in 2019.

Are these success stories financial flukes? Not according to a report by Deloitte, based on studies suggesting that “compared with a new construction, adaptive reuse and restoration can be 16 percent cheaper in terms of construction costs and take 18 percent less execution time.”

The benefit to the environment is a large consideration in repurposing as well, and the report speaks to this: “Also, if repurposing is done with smart and sustainable features in mind, it can help improve building performance and valuation.”

https://www.amexessentials.com/top-repurposed-industrial-spaces/

https://www.theatlantic.com/business/archive/2015/03/a-new-life-for-dead-malls/387001

https://www2.deloitte.com/us/en/pages/financial-services/articles/adaptive-reuse-of-commercial-real-estate.html

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More